Analog Devices joins Flagship Pioneering in a strategic partnership to accelerate the development of a fully digital biological world

     Analog Devices, Inc. and Flagship Pioneering, a bio-platform innovation company, have announced a strategic alliance to accelerate the development of a fully digital bio-world. The collaboration will combine ADI's expertise in analog and digital semiconductor engineering with Flagship Pioneering's expertise in applied biology to drive the discovery of biological insights as well as new and enhanced measurements, diagnostics and novel interventions. This collaboration presents a unique opportunity for both parties to create breakthrough solutions for human health and sustainable development.

     Specifically, the partnership will combine Flagship Pioneering's unique innovation process with ADI's advanced semiconductor technology, signal processing portfolio and physical world expertise to develop disruptive solutions and create new companies in the field of digital biology. The initial focus will be on bioelectronic platforms, regenerative agriculture, innovative applications of AI/ML, and preventive health and medicine. Future advances may further drive breakthroughs in next-generation protein sequencing, multi-omics research, early disease diagnosis, digital transformation of large-scale biological information, and drug design and optimization. The collaboration is the latest initiative in Flagship Pioneering's Enabling Technologies initiative, which is dedicated to pioneering new treatments by driving the development of advanced technologies.

     Vincent Roche, ADI's Chief Executive Officer and Chairman of the Board, said: "ADI's core mission is to accelerate breakthrough innovations that make our lives and the world better. Innovative technologies promise to help us achieve better and more active health care. We look forward to working with Flagship Pioneering in digital biology to put smart edge technology at the heart of developing innovative data-driven health solutions to address some of today's biggest challenges."

     Dr. Noubar Afeyan, founder and CEO of Flagship Pioneering, said: "Driven by technological leaps and a deep understanding of biology, we have entered a new era of innovation in biomedical and life sciences, which allows us to continually advance and improve the health of people and the planet. Flagship and ADI share a common vision and complementary strengths in accelerating the development of a fully digital biological world, harnessing the wisdom of nature to create preventive and therapeutic medicines, regenerative agriculture and solutions to the challenges of climate change."

     The collaboration will be driven by Flagship Pioneering's innovative process of pioneering and disseminating new technologies and biological insights that have already led to novel therapeutic approaches such as mRNA, tRNA and epigenetic regulation. ADI's current applications in sensing technology, microfabrication technology, and healthcare automation, including diagnostics, imaging, therapeutic devices, and continuous monitoring, will support the combined innovation driven by this collaboration. Flagship Pioneering scientists and entrepreneurs will work with ADI scientists and engineers to conceive and build new biological platforms that bring biology and technology together to drive innovation in human health and sustainability.